NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 309 filers reported holding NOVOCURE LTD in Q1 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $310,571 | -9.7% | 5,164 | +14.2% | 0.02% | -25.0% |
| Q3 2022 | $344,000 | +15.1% | 4,522 | +5.2% | 0.02% | +17.6% |
| Q2 2022 | $299,000 | -16.5% | 4,298 | -0.5% | 0.02% | 0.0% |
| Q1 2022 | $358,000 | +6.5% | 4,318 | -3.5% | 0.02% | 0.0% |
| Q4 2021 | $336,000 | -37.1% | 4,473 | -2.7% | 0.02% | -43.3% |
| Q3 2021 | $534,000 | -53.1% | 4,595 | -10.4% | 0.03% | -51.6% |
| Q2 2021 | $1,138,000 | +69.6% | 5,130 | +1.0% | 0.06% | +55.0% |
| Q1 2021 | $671,000 | -24.4% | 5,078 | -0.9% | 0.04% | -33.3% |
| Q4 2020 | $887,000 | +63.4% | 5,126 | +5.0% | 0.06% | +46.3% |
| Q3 2020 | $543,000 | +56.5% | 4,880 | -16.7% | 0.04% | +10.8% |
| Q2 2020 | $347,000 | – | 5,858 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $77,833,000 | 15.51% |
| HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
| Darsana Capital Partners LP | 700,000 | $155,274,000 | 4.42% |
| MORGAN JESS S & CO INC | 23,775 | $5,274,000 | 3.47% |
| Soleus Capital Management, L.P. | 98,975 | $21,955,000 | 3.38% |
| Montanaro Asset Management Ltd | 116,650 | $25,875,000 | 3.26% |
| Taylor Frigon Capital Management LLC | 31,035 | $6,884,000 | 2.15% |
| Rhenman & Partners Asset Management AB | 120,000 | $26,618,000 | 1.81% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $2,218,000 | 1.33% |
| Derbend Asset Management | 5,789 | $1,284,000 | 1.20% |